WVE - CIK 0001631574
Wave Life Sciences Ltd. (WVE) reported revenue of $42.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $42.73M | -60.5% |
| FY 2024 | $108.30M | -4.4% |
| FY 2023 | $113.31M | +3005.1% |
| FY 2022 | $3.65M | -91.1% |
| FY 2021 | $40.96M | +104.0% |
| FY 2020 | $20.08M | +25.6% |
| FY 2019 | $15.98M | +10.9% |
| FY 2018 | $14.41M | +270.3% |
| FY 2017 |
Wave Life Sciences Ltd. (WVE) reported revenue of $42.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2015 and fiscal 2025, Wave Life Sciences Ltd.'s revenue grew from $152.00K to $42.73M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.89M |
| +256.5% |
| FY 2016 | $1.09M | +618.4% |
| FY 2015 | $152.00K | - |